Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023)
Mirum Pharmaceuticals' quarterly Amortizatization of Intangibles came in at $29000.0 in Q4 2023, down 97.15% year-on-year from $1.0 million in Q4 2022, and down 87.61% quarter-over-quarter from $234000.0 in Q3 2023.
Mirum Pharmaceuticals has reported Amortizatization of Intangibles for 5 years, with the latest figure at $29000.0 in Q4 2023.
- For the quarter ending Q4 2023, Amortizatization of Intangibles fell 97.15% year-over-year to $29000.0; the trailing twelve-month figure through Dec 2023 stood at $1.7 million (up 1.29% YoY), and the FY2023 full-year result was $1.7 million, up 1.29% from the prior year.
- Amortizatization of Intangibles for Q4 2023 stood at $29000.0, down from $234000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.3 million in Q2 2023, with the low at -$166000.0 in Q4 2020.
- Average Amortizatization of Intangibles over 5 years is $198150.0, with a median of $76500.0 recorded in 2020.
- Year-over-year, Amortizatization of Intangibles plunged 230.71% in 2020 and soared 65800.0% in 2023.
- Tracing MIRM's Amortizatization of Intangibles over 5 years: stood at $127000.0 in 2019, then sank by 230.71% to -$166000.0 in 2020, then increased by 10.84% to -$148000.0 in 2021, then jumped by 787.16% to $1.0 million in 2022, then sank by 97.15% to $29000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $29000.0 (Q4 2023), $234000.0 (Q3 2023), and $1.3 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 583,000.00 |
| Sep 30, 2022 | 583,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 263,000.00 |
| Sep 30, 2021 | 263,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | -166,000.00 |
| Dec 31, 2020 | -166,000.00 |
| Sep 30, 2020 | 231,000.00 |
| Sep 30, 2020 | 231,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 127,000.00 |
| Dec 31, 2019 | 127,000.00 |
| Sep 30, 2019 | 127,000.00 |
| Sep 30, 2019 | 127,000.00 |
| Jun 30, 2019 | 45,000.00 |
| Jun 30, 2019 | 45,000.00 |
| Mar 31, 2019 | 27,000.00 |
| Mar 31, 2019 | 27,000.00 |